The Vodafone NZ-Sky merger is facing criticism from the telecommunications segment, with submissions accusing the two of trying to squeeze the competition out of the wholesale premium live sport and entertainment content market, the retail residential fixed-linebroadband market, the retail mobile broadband market, and the pay TV market.
The New Zealand Commerce Commission on Tuesday published submissionsfrom Spark, 2degrees, the Coalition for Better Broadcasting, Trustpower, and the Telecommunications Users Association of New Zealand it received in response to the Statement of Preliminary Issues released last month.
Spark identified the main issue as being premium sport, claiming that it is “essential” content for being able to attract telecommunications customers. Were the merger to go ahead, Sky’s sport content ownership would extend into Vodafone NZ’s mobile and broadband offerings, Spark said, and “distort competition” in those segments — including to the detriment of the New Zealand government’s Ultra-Fast Broadband project.
“Sky/Vodafone will bundle a further, competitive, product with its monopoly sports rights, and in doing so will reduce competition for that product. There is likely to be less innovation and less digital distribution of pay TV content; increased barriers to entry and expansion, and reduced switching between broadband suppliers; and lower uptake of UFB,” Spark argued.
Full Content: ZD Net
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas